Junya Kuroda

54PUBLICATIONS
88CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesGene and molecular therapyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Aug 24, 2026
Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.

|May 14, 2025
PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma.

Noriko Fukuhara, Isao Yoshida, Takuro Ishiguro

|Oct 22, 2024
Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities.

Haruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto

|Aug 19, 2024
Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63.

Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto

|May 25, 2024
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019.

Chie Yamamoto, Masashi Taniguchi, Keitaro Furukawa

|Apr 10, 2024
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.

Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi

Pageof 9

Frequent Collaborators

10 joint publications

Yuji Shimura

10 joint publications

Tsutomu Kobayashi

8 joint publications

Takahiro Fujino

6 joint publications

Shinsuke Mizutani